A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: Evidence for its exposure on the surface of the virion

Journal of General Virology

Volumn 84, Issue 3, 2003, Pages 591-602

  Cleveland, S Matthew ^a,c   McLain, Lesley ^a   Cheung, Linda ^a   Jones, Tim D ^b   Hollier, Mark ^a   Dimmock, Nigel J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b Axis Genetics plc   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEINASE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CENTRIFUGATION; CONTROLLED STUDY; ENZYME METABOLISM; EXPOSURE; GENE DELETION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID MEMBRANE; MUTANT; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; TEMPERATURE; VIRION; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; CELL LINE; ENDOPEPTIDASES; EPITOPE MAPPING; EPITOPES; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037370395     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18630-0     Document Type: Article

References (84)

1. Abacioglu, Y. H., Fouts, T. R., Laman, J. D., Classen, E., Pincus, S. H., Moore, J. P., Roby, C. A., Kamin-Lewis, R. & Lewis, G. K. (1994). Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retrovir 10, 371-381.
2. Arroyo, J., Boceta, M., González, M. E., Michel, M. & Carrasco, L. (1995). Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J Virol 69, 4095-4102.
3. Berlioz-Torrent, C., Shacklett, B. L., Erdtmann, L., Delamarre, L., Bouchaert, I., Sonigo, P., Dokhelar, M. C. & Benarous, R. (1999). interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adapter complexes modulate intracellular and cell surface expression of envelope glycoprotein. J Virol 73, 1350-1361.
4. Blacklow, S. C., Lu, M. & Kim, P. S. (1995). A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 34, 14955-14962.
5. Bukrinskaya, A. G. & Sharova, N. K. (1990). Unusual features of protein interaction in human immunodeficiency virus (HIV) virions. Arch Virol 110, 287-293.
6. Buratti, E., Tisminetzky, S. G., Scodeller, E. S. & Baralle, F. E. (1996). Conformational display of two neutralizing epitopes of HIV-1 gp41 in the flock house virus capsid protein. J Immunol Methods 197, 7-18.
7. Buratti, E., Tisminetzky, S. G., D'Agaro, P. & Baralle, F. E. (1997). A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE. J Virol 71, 2457-2462.
8. Buratti, E., McLain, L., Tisminetzky, S. G., Cleveland, S. M., Dimmock, N. J. & Baralle, F. E. (1998). The neutralizing antibody response against a conserved region of HIV-1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope. J Gen Virol 79, 2709-2716.
9. Burton, D. R. (1997). A vaccine for HIV type 1: the antibody perspective. Proc Natl Acad Sci U S A 94, 10018-10023.
10. Burton, D. R., Pyati, J., Koduri, R. & 15 other authors (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
11. Celma, C. C. P., Manrique, J. M., Affranchino, J. L., Hunter, E. & González, S. A. (2001). Domains in the simian immunodeficiency virus gp41 cytoplasmic tail required for envelope incorporation into particles. Virology 283, 253-261.
12. Chan, D. C., Fass, D., Berger, J. & Kim, P. S. (1997). Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273.
13. Chanh, T. C., Dreesman, G., Kanda, P., Linette, G. P., Sparrow, J. T., Ho, D. D. & Kennedy, R. C. (1986). Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J 5, 3065-3071.
14. Chernomordik, L., Chanturiya, A. N., Suss-Toby, E., Nora, E. & Zimmerberg, J. (1994). An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J Virol 68, 7115-7123.
15. Cleveland, S. M., Buratti, E., Jones, T. D., North, P., Baralle, F. E., McLain, L., McInerney, T. L., Durrani, Z. & Dimmock, N. J. (2000a). Immunogenic and antigenic dominance of a non-neutralizing epitope over a highly conserved neutralizing epitope in the gp41 transmembrane envelope glycoprotein of HIV-1: its deletion leads to a strong neutralizing antibody response. Virology 266, 66-78.
16. Cleveland, S. M., Jones, T. D. & Dimmock, N. J. (2000b). Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the C-terminal tail of human immunodeficiency virus type 1. J Gen Virol 81, 1251-1260.
17. Comardelle, A. M., Norris, C. H., Plymale, D. R. & 8 other authors (1997). A synthetic peptide corresponding to the carboxyterminus of human immunodeficiency virus type 1 transmembrane protein induces alterations in the ionic permeability of Xenopus laevis oocytes. AIDS Res Hum Retrovir 13, 1525-1532.
18. Cosson, P. (1996). Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 15, 5783-5788.
19. Dalgleish, A. G., Chanh, T. C., Kennedy, R. C., Kanda, P., Clapham, P. R. & Weiss, R. A. (1988). Neutralization of diverse strains of HIV-1 by monoclonal antibodies raised against a gp41 synthetic peptide. Virology 165, 209-215.
20. Davis, D., Chaudri, B., Stephens, D. M., Carne, C. A., Willers, C. & Lachmann, P. J. (1990). The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be related by the host's previous exposure to similar epitopes on unrelated antigens. J Gen Virol 71, 1975-1983.
21. Di Fiore, P. P. & Gill, G. N. (1999). Endocytosis and mitogenic signalling. Curr Opin Cell Biol 11, 483-488.
22. Dorfman, T., Mammano, F., Haseltine, W. A. & Göttlinger, H. G. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope protein. J Virol 68, 1689-1696.
23. Durrani, Z., McInerney, T. L., McLain, L., Jones, T., Bellaby, T., Brennan, F. R. & Dimmock, N. J. (1998). Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization. J Immunol Methods 220, 93-103.
24. Edwards, T. G., Hoffman, T. L., Baribaud, F. & 7 other authors (2001). Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol 75, 5230-5239.
25. Edwards, T. G., Wyss, S., Reeves, J. D., Zolla-Pazner, S., Hoxie, J. A., Doms, R. W. & Baribaud, F. (2002). Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. J Virol 76, 2683-2691.
26. Eisenberg, D. & Wesson, M. (1990). The most highly amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41. Biopolymers 29, 171-177.
27. Eisenberg, D., Weiss, R. M. & Terwilliger, T. C. (1982). The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 299, 371-374.
28. Evans, D. J., McKeating, J. A., Meredith, J. M., Burke, K. L., Katrak, K., Ferguson, M., Minor, P. D., Weiss, R. A. & Almond, J. W. (1989). An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385-388.
29. Freed, E. O. & Martin, M. A. (1995a). The role of the human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J Biol Chem 270, 23883-23886.
30. Freed, E. O. & Martin, M. A. (1995b). Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 69, 1984-1989.
31. Freed, E. O. & Martin, M. A. (1996). Domains on the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol 70, 341-351.
32. Fultz, P. N., Vance, P. J., Endres, M. J. & 8 other authors (2001). In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail. J Virol 75, 278-291.
33. Gallagher, W. R., Henderson, L. A., Fermin, C. & 7 other authors (1992). Membrane interactions of human immunodeficiency virus: attachment, fusion, and cytopathology. Adv Membrane Fluidity 6, 113-142.
34. Gawrisch, K., Han, K.-H., Yang, J., Bergelson, L. D. & Ferretti, J. A. (1993). Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type 1 with lipid bilayers. Biochemistry 32, 3112-3118.
35. Haffar, O. K., Dowbenko, D. & Berman, P. W. (1988). Topogenic analysis of the HIV-1 envelope glycoprotein, gp160, in microsomal membranes. J Cell Biol 107, 1677-1687.
36. Haffar, O. K., Dowbenko, D. & Berman, P. W. (1991). The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes. Virology 180, 439-441.
37. Heilker, R., Spiess, M. & Crottet, P. (1999). Recognition of sorting signals by clathrin adapters. Bioessays 7, 558-567.
38. Iwatani, Y., Ueno, T., Nishimura, A., Zhang, X., Hattori, T., Ishimoto, A., Ito, M. & Sakai, H. (2001). Modification of virus infectivity by cytoplasmic tail of HIV-1 TM protein. Virus Res 74, 75-87.
39. Jackson, N. A. C., Levi, M., Wahren, B. & Dimmock, N. J. (1999). Mechanism of action of a 17 amino acid microantibody specific for the V3 loop that neutralizes free HIV-1 virions. J Gen Virol 80, 225-236.
40. Kalyan, N. K., Lee, S.-G., Wilhelm, J. & 7 other authors (1994). Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1. Vaccine 12, 753-760.
41. Kennedy, R. C., Henkel, R. D., Pauletti, D., Allan, J. S., Lee, T. H., Essex, M. & Dreesman, G. R. (1986). Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science 231, 1556-1559.
42. Kyte, J. & Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105-132.
43. Levy, J. A. (1998). HIV and the Pathogenesis of AIDS, 2nd edn. Herndon, VA: ASM Press.
44. Li, Q., Yafal, A. G., Lee, Y. M.-H., Hogle, J. & Chow, M. (1994). Poliovirus neutralization by antibodies to internal epitopes of VP4 an VP1 results from reversible exposure of these sequences at physiological temperature. J Virol 68, 3965-3970.
45. Lifson, S. & Sander, M. (1979). Antiparallel and parallel β-strands differ in amino acid residue preferences. Nature 282, 109-111.
46. Lu, M., Blacklow, S. C. & Kim, P. S. (1995). A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol 2, 1074-1082.
47. McInerney, T. L., Brennan, F. R., Jones, T. D. & Dimmock, N. J. (1999). Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying a HIV-1 peptide. Vaccine 17, 1359-1368.
48. McKeating, J. A., Cordell, J. A., Dean, C. J. & Balfe, P. (1992). Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191, 732-742.
49. McLain, L. & Dimmock, N. J. (1994). Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. J Gen Virol 75, 1457-1460.
50. McLain, L., Porta, C., Lomonossoff, G. P., Durrani, Z. & Dimmock, N. J. (1995). Human immunodeficiency virus type 1 neutralizing antibodies raised to a gp41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retrovir 11, 327-334.
51. McLain, L., Durrani, Z., Wisniewski, L. A., Porta, C., Lomonossoff, G. P. & Dimmock, N. J. (1996a). A plant virus-HIV-1 chimera stimulates antibody that neutralizes HIV-1. In Vaccine 96, pp. 311-316. Edited by F. Brown, D. R. Burton, J. Collier, J. Mekalonos & E. Norrby. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
52. McLain, L., Durrani, Z., Wisniewski, L. A., Porta, C., Lomonossoff, G. P. & Dimmock, N. J. (1996b). Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22-mer amino acid peptide expressed on the surface of a plant virus. Vaccine 14, 799-810.
53. McLain, L., Brown, J. L., Cheung, L., Reading, S. A., Parry, C., Jones, T. D., Cleveland, S. M. & Dimmock, N. J. (2001). Different effects of a single amino acid substitution on three epitopes in the gp41 C-terminal loop of a neutralizing antibody escape mutant of human immunodeficiency virus type 1. Arch Virol 146, 157-166.
54. Mammano, F., Kondo, E., Sodroski, J., Bukovsky, A. & Göttlinger, H. G. (1995). Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic tails. J Virol 69, 3824-3830.
55. Manrique, J. M., Celma, C. C. P., Affranchino, J. L., Hunter, E. & González, S. A. (2001). Small variations in the length of the cytoplasmic domain of the simian immunodeficiency virus transmembrane protein drastically affect envelope incorporation and virus entry. AIDS Res Hum Retrovir 17, 1615-1624.
56. Miller, M. A., Garry, R. F., Jaynes, G. J. & Montelaro, R. C. (1991). A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retrovir 7, 511-519.
57. Miller, M. A., Cloyd, M. W., Liebmann, J., Rinaldo, C. R., Islam, K. R., Wang, S. Z. S., Mietzner, T. A. & Montelaro, R. C. (1993). Alterations in cell membrane permeability by the lentiviral peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196, 89-100.
58. Modrow, S., Hahn, B. H., Shaw, G. M., Gallo, R. C., Wong-Staal, F. & Wolf, H. (1987). Computer assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol 61, 570-578.
59. Mulligan, M. J., Yamshchikov, G. V., Ritter, G. D., Gao, F., Jin, M. J., Nail, C. D., Spies, C. P., Hahn, B. H. & Compans, R. W. (1992). Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in certain cell types. J Virol 66, 3971-3975.
60. Murakami, T. & Freed, E. O. (2000a). Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix protein and alpha-helix 2 of the gp41 cytoplasmic tail. J Virol 74, 3548-3554.
61. Murakami, T. & Freed, E. O. (2000b). The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc Natl Acad Sci U S A 97, 343-348.
62. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F. & Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67, 6642-6647.
63. Newton, S. M. C., Joys, T. M., Anderson, S. A., Kennedy, R. C., Hovi, M. E. & Stocker, B. A. D. (1995). Expression and immunogenicity of an 18-residue epitope of HIV-1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Res Microbiol 146, 203-216.
64. Niedrig, M., Bröker, M., Walter, G., Stüber, W., Harthus, H.-P., Mehdi, S., Gelderblom, H. R. & Pauli, G. (1992). Murine monoclonal antibodies directed against the transmembrane protein gp41 of human immunodeficiency virus type 1 enhance its infectivity. J Gen Virol 73, 951-954.
65. Piller, S. C., Dubay, J. W., Derdeyn, C. A. & Hunter, E. (2000). Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity. J Virol 74, 11717-11723.
66. Pincus, S. H., Messer, K. G., Schwartz, D. H., Lewis, G. K., Graham, B. S., Blattner, W. A. & Fisher, G. (1993). Differences in the antibody response to human immunodeficiency virus type 1 envelope protein (gp160) in infected laboratory workers and vaccinees. J Clin Invest 91, 1987-1996.
67. Ratner, L., Haseltine, W., Patarca, R. & 16 other authors (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
68. Sattentau, Q. J., Zolla-Pazner, S. & Poignard, P. (1995). Epitopes exposed on functional, oligomeric gp41 molecules. Virology 206, 713-717.
69. Sauter, M. M., Pelchen-Matthews, A., Bron, R. & 8 other authors (1996). An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J Cell Biol 132, 795-811.
70. Schirmer, T. (1998). General and specific porins from bacterial outer membranes. J Struct Biol 121, 101-109.
71. Schirmer, T. & Cowan, S. W. (1993). Prediction of membrane-spanning β-strands and its application to maltoporin. Protein Sci 2, 1361-1363.
72. Sodroski, J., Goh, W. C., Rosen, C., Campbell, K. & Haseltine, W. A. (1986). Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322, 470-474.
73. Spies, C. P., Ritter, G. D., Mulligan, M. J. & Compans, R. W. (1994). Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol 68, 585-591.
74. Srinivas, S. K., Srinivas, R. V., Anatharamaiah, G. M., Segrest, J. P. & Compans, R. W. (1992). Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type 1 with lipid bilayers. J Biol Chem 267, 7121-7127.
75. Vella, C., Minor, P. D., Weller, I. V. D., Jenkins, O., Evans, D. & Almond, J. (1991). Recognition of poliovirus/HIV chimeras by antisera from individuals with HIV infection. AIDS 5, 425-430.
76. Vella, C., Ferguson, M., Dunn, G., Meloen, R., Langedijk, H., Evans, D. & Minor, P. D. (1993). Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera. J Gen Virol 74, 2603-2607.
77. Venable, R. M., Pastor, R. W., Brooks, B. R. & Carson, F. W. (1989). Theoretically determined three-dimensional structure for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res Hum Retrovir 5, 7-22.
78. Vzorov, A. N. & Compans, R. W. (2000). Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization. J Virol 74, 8219-8225.
79. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. & Wiley, D. C. (1997). Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430.
80. Wilk, T., Pfeiffer, T. & Bosch, V. (1992). Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189, 167-177.
81. Gag in immature human immunodeficiency virus type 1 particles. J Virol 74, 9381-9387.
82. Yu, X., Yuan, X., McLane, M. F., Lee, T.-H. & Essex, M. (1993). Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Environ proteins into mature virions. J Virol 67, 213-221.
83. Zhang, H., Dornadula, G., Alur, P., Laughlin, M. A. & Pomerantz, R. J. (1996). Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription. Proc Natl Acad Sci U S A 93, 12519-12524.
84. Zingler, K. & Littman, D. R. (1993). Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Environ incorporation into particles and fusogenicity and infectivity. J Virol 67, 2824-2831.